Technology Level, Market Competition, and Firms’ Innovation Behavior: Evidence from Chinese High-Tech Enterprises

Hui-hong, Liu; Zhou, Xuebing

doi:10.1142/9789811212239_0011

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Published by Francis Academic Press, UK -64-Peiwei (2015) evaluated the innovation capability of pharmaceutical high-tech enterprises in the three northeastern provinces of China using factor analysis [8]. Guo Xiuqiang (2020) and colleagues employed the Analytic Hierarchy Process with entropy weights to analyze the innovation level of high-tech industries in Guangdong Province, achieving favorable results [9].…”

Section: Literature Reviewmentioning

confidence: 99%

Research on Evaluation of Dongguan Pharmaceutical Innovation Ability under the Background of Industrial Transformation and Upgrading Strategy

2023

AJHSS

View full text Add to dashboard Cite

In the context of the "Healthy China" initiative and the strategy of industrial transformation and upgrading, pharmaceutical innovation capability has emerged as an indispensable and crucial element for the development of the "Healthy China" strategy. This paper first comprehensively reviews theoretical perspectives on domestic and international pharmaceutical innovation capability research. Subsequently, it deeply analyzes the multiple factors influencing the pharmaceutical innovation capability in Dongguan. The study adopts the expert consultation method to establish evaluation criteria, utilizes the Analytic Hierarchy Process (AHP) to determine indicator weights and validate their rationality, and ultimately applies a fuzzy comprehensive evaluation model to process and analyze the data. The research results indicate that the constructed pharmaceutical innovation capability evaluation system exhibits significant advantages in terms of scientificity and practicality. The analysis of the comprehensive evaluation values reveals a positive development trend in Dongguan's pharmaceutical innovation capability, with the composite index continuously rising. However, it is still necessary to strengthen relevant policy support in order to promote the sustainable development of pharmaceutical innovation in Dongguan.

show abstract

Section: Literature Reviewmentioning

confidence: 99%

Research on Evaluation of Dongguan Pharmaceutical Innovation Ability under the Background of Industrial Transformation and Upgrading Strategy

2023

AJHSS

View full text Add to dashboard Cite

show abstract

Technology Level, Market Competition, and Firms’ Innovation Behavior: Evidence from Chinese High-Tech Enterprises

Cited by 1 publication

References 0 publications

Research on Evaluation of Dongguan Pharmaceutical Innovation Ability under the Background of Industrial Transformation and Upgrading Strategy

Research on Evaluation of Dongguan Pharmaceutical Innovation Ability under the Background of Industrial Transformation and Upgrading Strategy

Contact Info

Product

Resources

About